Status:

RECRUITING

Phenotype, Genotype and Biomarkers 2

Lead Sponsor:

University of Miami

Collaborating Sponsors:

National Institutes of Health (NIH)

National Institute of Neurological Disorders and Stroke (NINDS)

Conditions:

Amyotrophic Lateral Sclerosis

Hereditary Spastic Paraplegia

Eligibility:

All Genders

7+ years

Brief Summary

The purpose of this study is to learn more about amyotrophic lateral sclerosis (ALS) and other related neurodegenerative diseases, including frontotemporal dementia (FTD), primary lateral sclerosis (P...

Eligibility Criteria

Inclusion

  • Inclusion Criteria for affected individuals (primary participants) include:
  • Clinical diagnosis or suspicion of ALS or a related disorder, including, but not limited to, ALS-FTD, PLS, HSP, FTD, Multisystem Proteinopathy (MSP) and PMA.
  • Subject is able and willing to comply with study procedures
  • Exclusion Criteria for affected individuals (primary participants) include:
  • Subjects with a condition or who are in a situation which, in the PI's opinion, could confound the study finding or may interfere significantly with the individual's participation and compliance with the study protocol -- including but not limited to neurological, psychological and/or medical conditions
  • Inclusion criteria for biological family members (secondary participants) include:
  • Family member of an enrolled affected primary participant
  • Exclusion Criteria for biological family members (secondary participants) include:
  • Subjects with a condition or who are in a situation which, in the PI's opinion, could confound the study finding or may interfere significantly with the individual's participation and compliance with the study protocol -- including but not limited to neurological, psychological and/or medical conditions

Exclusion

    Key Trial Info

    Start Date :

    January 8 2021

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    August 1 2028

    Estimated Enrollment :

    300 Patients enrolled

    Trial Details

    Trial ID

    NCT04875416

    Start Date

    January 8 2021

    End Date

    August 1 2028

    Last Update

    August 28 2025

    Active Locations (4)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (4 locations)

    1

    University of Miami

    Miami, Florida, United States, 33136

    2

    University of Kansas Medical Center

    Kansas City, Kansas, United States, 66160

    3

    University of Pennsylvania

    Philadelphia, Pennsylvania, United States, 19104

    4

    University of Cape Town

    Cape Town, South Africa